Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
Year: 2021
Type: article
Source: Clinical Genitourinary Cancer
Institutions: Unidade Local de Saúde de Coimbra, Dana-Farber Cancer Institute, Haukeland University Hospital, University of Bergen, University of Cambridge, Royal Bournemouth Hospital, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Umeå University, Lund University, Skåne University Hospital, Royal Free London NHS Foundation Trust, The Netherlands Cancer Institute, University College London
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3119567495